Feb 06, 2018 06:51 am UTC| Business
NEW YORK, Feb. 06, 2018 -- According to a new research report titled “Androgenic Alopecia Therapeutics Pipeline Analysis, 2017 - Clinical Trials Results, Patent, Designation, Collaboration, and Other Developments”...
ALK releases its annual report 2017
Feb 06, 2018 06:31 am UTC| Business
The Board of Directors of ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today considered and approved the 2017 annual report with the following highlights[1]: Q4 2017 performance Q4 results were in line with ALK's most...
TECHNICOLOR: TECHNICOLOR ESTABLISHES MILL FILM, A NEW VFX COMPANY IN SOUTH AUSTRALIA
Feb 06, 2018 06:31 am UTC| Business
PRESS RELEASE TECHNICOLOR ESTABLISHES MILL FILM, A NEW VFX COMPANY IN SOUTH AUSTRALIA Paris (France), 6...
Global Biologics Outsourcing Market Will Reach USD 32,000.0 Million by 2024: Zion Market Research
Feb 06, 2018 06:20 am UTC| Business
New York, Feb. 06, 2018 -- Zion Market Research has published a new report titled “Biologics Outsourcing Market by Product (Antibody, Recombinant Protein, Vaccines, and Others), by Type (Kits Reagents and Instruments),...
Feb 06, 2018 06:11 am UTC| Business
REGULATED INFORMATION GHENT, Belgium, 6 February 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major...
Feb 06, 2018 06:01 am UTC| Business
REGULATED INFORMATION GHENT, Belgium, 6 February 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major...
Feb 06, 2018 06:01 am UTC| Business
Oslo, Norway, 6 February 2018 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, will announce its fourth quarter 2018 results on Thursday, 15...